Kyle Piskel, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 10,320 shares at $6.97 ($72K) on 2025-03-05, disclosed to the SEC on 2025-03-06.
Seasonal sale ($72k) by Chief Financial Officer — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.97 | 3,103 | $22K | 30.0% |
| 2 | $6.98 | 253 | $2K | 2.5% |
| 3 | $6.99 | 6,964 | $49K | 67.5% |
| Total | $6.98 avg | 10,320 | $72K | 100% |
| Filing → |
| ADPT | SELL | 2026-02-06 | $40K | — | Filing → |
| ADPT | SELL | 2026-01-14 | $77K | — | Filing → |
| ADPT | SELL | 2025-12-02 | $3.2M | — | Filing → |